Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/7/22 → 4/6/23 |
Funding
- Cognitive Research Corporation: $2.00
NM201: A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's Disease (PD) Participants Treated with Carbidopa/Levodopa and NE3107
- Slevin, John (PI)